"Carol Davila" University of Medicine and Pharmacy of Bucharest, Bucharest, Romania.
Colentina Clinical Hospital, Bucharest, Romania.
Rom J Intern Med. 2020 Jun 1;58(2):99-107. doi: 10.2478/rjim-2020-0006.
Studies regarding antibiotics administration during pregnancy and atopic dermatitis (AD) in children are only few. In this context, the objective of our study was to investigate the potential association between the timing of intrauterine exposure to antibiotics or prenatal antibiotic administration in general and AD occurrence in children.
This was a cross-sectional study in 1046 subjects. The exposure to antibiotics during pregnancy was initially evaluated using simple logistic regressions. Then, each period of antibiotics administration was adjusted with the other periods of antibiotics exposure (model 1) and with the other variables associated with AD in our database (model 2).
In simple logistic regression analysis, the administration of antibiotics during pregnancy, as a whole period, presented a trend of association with AD (OR = 1.28, %CI: 0.99 - 1.65). When we analyzed antibiotic administration during each trimester of pregnancy, only antibiotherapy during the 3rd trimester was associated with AD (OR = 2.94, %CI: 1.21 - 7.12). After adjusting with all the other important risk factors associated with AD in the database, antibiotics administration during the 3rd trimester of pregnancy was still independently associated with AD (OR=2.64, %CI: 1.01 - 6.91).
Antibiotic administration during the 3rd trimester of pregnancy was independently associated with AD in children.
关于孕妇和儿童特应性皮炎(AD)中抗生素使用的研究较少。在这种情况下,我们的研究目的是调查宫内暴露于抗生素或产前抗生素使用的时间与儿童 AD 发生之间的潜在关联。
这是一项针对 1046 名受试者的横断面研究。最初使用简单的逻辑回归评估怀孕期间接触抗生素的情况。然后,将每个抗生素使用期与其他抗生素暴露期(模型 1)和我们数据库中与 AD 相关的其他变量(模型 2)进行调整。
在简单的逻辑回归分析中,整个孕期使用抗生素呈与 AD 相关的趋势(OR=1.28,99%CI:0.99-1.65)。当我们分析怀孕期间每个三个月的抗生素使用情况时,只有第三个月的抗生素治疗与 AD 相关(OR=2.94,99%CI:1.21-7.12)。在调整数据库中与 AD 相关的所有其他重要风险因素后,孕期第三个月的抗生素使用仍与 AD 独立相关(OR=2.64,99%CI:1.01-6.91)。
孕期第三个月的抗生素使用与儿童 AD 独立相关。